REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/25/2026
Back to search
Official data from USPTO
DISCOVID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
05/26/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
07/01/2020
Registration date
05/25/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/25/2021
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/31/2020
First use in commerce
05/31/2020
Drawing code
4
Owner type
03
Owner location
Boston, MA, US
Examiner
PIERCE, ALEXANDRA
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Antagen Biosciences, Inc.
Representatives
DUAN WU MILSTEIN ZHANG & WU LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectionCOVID-19 or coronavirus infection; Diagnostic reagents for medicinal use; Diagnostic biomarker reagents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Reagents and media for medical and veterinary diagnostic purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; all the foregoing goods for detecting and preventing the transmission of the coronavirus
Publications
History of USPTO decisions and trademark events.
13 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/25/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBO
PUBLISHED FOR OPPOSITION
03/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
01/29/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/29/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
01/29/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/29/2021
DOCK
ASSIGNED TO EXAMINER
01/22/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2020
NWAP
NEW APPLICATION ENTERED
07/04/2020
Continuous trademark protection
Get notified about every new filing that threatens DISCOVID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.